Results from the EARLY TAVR trial — the first randomized, controlled FDA pivotal study designed to determine the best ...

Wandercraft announced today that it enrolled the first participants in a clinical trial evaluating its Personal Exoskeleton ...

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

VVT Medical, a developer of minimally invasive treatments for venous insufficiency, says it has received conditional approval ...

SS Innovations has also announced regulatory approvals for its SSi Mantra 3 surgical robotic system in the Philippines and ...

GE HealthCare is also using ACC 2025 to highlight new AI-powered innovations for cardiac care: The latest version of CASE (Cardiac Assessment System for Stress Testing), powered by the company’s ...